Furthermore, IHC analysis revealed elevated expression of XPG in gastric tumors compared with benign lesions, indicating its involvement in malignancy progression and suggesting the utilization of XPG as a promising diagnostic biomarker [21]. Here, ERCC5 is linked to gastric neoplasm.